Sponsor: University of Miami Sylvester Comprehensive Cancer Center
Sex: Female
Age: 21+
Code: NCT05721976
Recruiting
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
for
Recurrent Endometrial Cancer
Location: Miami FL
Sponsor: University of Miami
Sex: Female
Age: 18+
Code: NCT07594015
Phase2, Recruiting
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
for
Endometrioid Endometrial Adenocarcinoma
Location: Gainesville FL
Sponsor: University of Florida
Sex: Female
Age: 18+
Code: NCT07107334
Phase2, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma